Analystreport

Eleven Biotherapeutics Inc (NASDAQ: EBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

ELEVEN BIOTHERAPEUTICS  (EBIO) 
Last eleven biotherapeutics earnings: 5/15 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.elevenbio.com/investor-relations